Clinical trial
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
NCT04450394
Study timeline
Study start (actual)2020-07-01Date precision: day
Registry last updated2022-11-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
LY3209590DRUG
Insulin DegludecDRUG · verified · RxNorm: insulin degludec
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04450394 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.